Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk-Reference-Cited by-同舟云学术

Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk

Published:2013-08-18 Issue:10 Volume:45 Page:1221-1225
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

Chubb Daniel,Weinhold Niels,Broderick Peter,Chen Bowang,Johnson David C^ORCID,Försti Asta,Vijayakrishnan Jayaram,Migliorini Gabriele,Dobbins Sara E,Holroyd Amy,Hose Dirk,Walker Brian A,Davies Faith E,Gregory Walter A,Jackson Graham H,Irving Julie A,Pratt Guy,Fegan Chris,Fenton James A L,Neben Kai,Hoffmann Per^ORCID,Nöthen Markus M,Mühleisen Thomas W,Eisele Lewin,Ross Fiona M,Straka Christian,Einsele Hermann,Langer Christian,Dörner Elisabeth,Allan James M,Jauch Anna,Morgan Gareth J,Hemminki Kari,Houlston Richard S,Goldschmidt Hartmut

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

http://www.nature.com/articles/ng.2733.pdf

Reference49 articles.

1. Kyle, R.A. & Rajkumar, S.V. Multiple myeloma. N. Engl. J. Med. 351, 1860–1873 (2004).

2. Palumbo, A. & Anderson, K. Multiple myeloma. N. Engl. J. Med. 364, 1046–1060 (2011).

3. Broderick, P. et al. Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk. Nat. Genet. 44, 58–61 (2012).

4. Weinhold, N. et al. The CCND1 G870A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma. Nat. Genet. 45, 522–525 (2013).

5. Schmermund, A. et al. Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: rationale and design of the Heinz Nixdorf RECALL Study. Risk factors, evaluation of coronary calcium and lifestyle. Am. Heart J. 144, 212–218 (2002).

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disease prediction with multi-omics and biomarkers empowers case–control genetic discoveries in the UK Biobank;Nature Genetics;2024-09

2. Haplotype analysis identifies functional elements in monoclonal gammopathy of unknown significance;Blood Cancer Journal;2024-08-20

3. Deciphering the genetics and mechanisms of predisposition to multiple myeloma;Nature Communications;2024-08-05

4. Multiple myeloma;Nature Reviews Disease Primers;2024-06-27

5. SOHO State of the Art Updates and Next Questions: Diagnosis and Management of Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma;Clinical Lymphoma Myeloma and Leukemia;2024-03